GABA and Astaxanthin Improve Markers of Streptozotocin-Induced Type 1 Diabetes in Rats: Additive Effects of Combination Therapy
Jundishapur Journal of Natural Pharmaceutical Products · 07.01.2026 · 21 (1)
DOI: 10.5812/jjnpp-161869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Natural Pharmaceutical Products, online erschienen am 07.01.2026. Verfasst von Alireza Lotfi und 5 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 1 diabetes (T1D) is an autoimmune disease primarily caused by inflammation and oxidative stress. The treatment of this condition has encountered numerous challenges and limitations to date. Astaxanthin (AST) is a carotenoid known for its antioxidant properties. Gamma-aminobutyric acid (GABA) is a vital neurotransmitter that regulates the activity of beta cells in pancreatic islets.
Objectives
The present study aimed to investigate the effects of AST and GABA alone and in combination on beta cell regeneration, fasting blood sugar (FBS), and oxidative stress in streptozotocin (STZ)-induced T1D in rats.
Methods
In this experimental in vivo study, 30 male Wistar rats were used. Diabetes was induced with intraperitoneal injection of STZ (55 mg/kg). We randomly divided the rats into five groups (n = 6): control, diabetic, AST (20 mg/kg), GABA (100 mg/kg), and combination therapy (GABA + AST). Following 21 days of treatment, we measured serum FBS, C-peptide, insulin, nitric oxide (NO), and total antioxidant capacity (TAC). We removed the rats’ pancreases to examine gene expression (PDX1, NEUROG3) and histological changes.
Results
The FBS and NO levels of treated diabetic rats with GABA, AST, and their combination decreased significantly (P < 0.05). The amount of C-peptide, insulin, TAC, and expression of PDX1 and NEUROG3 genes increased significantly.
Conclusions
AST and GABA reduce FBS and improve serum and histology factors of the pancreas in diabetic rats.
Zitieren
APA
Lotfi, A., Khazaei, M. R., Fakhri, S., Ghanbari, E., Bozorgi, M., & Khazaei, M. (2026). GABA and Astaxanthin Improve Markers of Streptozotocin-Induced Type 1 Diabetes in Rats: Additive Effects of Combination Therapy. Jundishapur Journal of Natural Pharmaceutical Products, 21(1). https://doi.org/10.5812/jjnpp-161869
Vancouver
Lotfi A, Khazaei MR, Fakhri S, Ghanbari E, Bozorgi M, Khazaei M. GABA and Astaxanthin Improve Markers of Streptozotocin-Induced Type 1 Diabetes in Rats: Additive Effects of Combination Therapy. Jundishapur Journal of Natural Pharmaceutical Products. 2026;21(1). doi:10.5812/jjnpp-161869
BibTeX
@article{Lotfi2026,
author = {Lotfi, Alireza and Khazaei, Mohammad Rasool and Fakhri, Sajad and Ghanbari, Elham and Bozorgi, Maryam and Khazaei, Mozafar},
title = {GABA and Astaxanthin Improve Markers of Streptozotocin-Induced Type 1 Diabetes in Rats: Additive Effects of Combination Therapy},
journal = {Jundishapur Journal of Natural Pharmaceutical Products},
year = {2026},
volume = {21},
number = {1},
doi = {10.5812/jjnpp-161869}
}
EUVIMED